Skip to main content
SKYE filings

Corporate insider profile

Scott M Rocklage Filing Activity

Latest reported as Corporate insider of Skye Bioscience, Inc. (SKYE).

Purchase filings
0
Reported companies
2
Net open-market value
-$1,443,891.75
Latest transaction
Sep 16, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 16, 2026Skye Bioscience, Inc. (SKYE)Corporate insiderSale33,892$1.91$64,734
Aug 20, 2026Skye Bioscience, Inc. (SKYE)Corporate insiderSale375,840$0.37$140,301
Aug 7, 2026Entrada Therapeutics, Inc. (TRDA)Corporate insiderSale62,811$6.88$431,832